AstraZeneca PLC Profile Avatar - Palmy Investing

AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza…
Drug Manufacturers - General
GB, Cambridge [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2014 1.0200 2.090 25,711 25,883 2,556 1,070 8,345 5,287 3,712 1,924 12,512 11,230
2015 0.4900 2.123 26,095 24,404 1,233 2,886 5,491 7,080 2,137 4,239 13,324 22,788
2016 1.1200 2.107 24,708 22,787 2,825 3,546 6,996 7,356 4,114 4,899 11,451 13,669
2017 1.3900 1.895 23,002 22,097 3,499 2,333 7,293 5,196 4,902 3,120 9,739 18,711
2018 1.1900 1.687 22,465 21,961 3,001 2,209 6,771 7,482 3,677 3,528 10,543 10,875
2019 0.8500 1.794 22,090 24,362 2,155 1,303 7,165 6,762 3,387 2,783 10,362 10,047
2020 0.5100 2.094 24,384 26,377 1,335 3,191 7,016 8,262 3,198 5,115 11,848 13,181
2021 1.2200 2.593 26,617 36,411 3,196 -238 8,371 7,275 5,162 666 11,693 16,201
2022 0.0400 3.359 37,417 44,439 112 -1,382 7,565 7,573 1,056 -184 15,680 19,775
2023 1.0600 3.669 44,351 45,812 3,288 6,440 9,327 8,331 3,757 -203 18,955 21,753
2024 1.9200 4.074 45,811 52,395 5,955 12,726 13,911 13,815 8,722 7,960 18,222 22,733
2025 - 4.687 - 56,615 - 15,200 - 14,928 - 8,601 - 24,564
2026 - 5.168 - 60,040 - 2.F12X/td> - 2.F121/td> - 2.F121 - 2.F121
2027 - 5.755 - 63,759 - 1.F13X/td> - 1.F131/td> - 1.F131 - 1.F131
2028 - 6.156 - 66,727 - 0.F14X/td> - 0.F141/td> - 0.F141 - 0.F141
Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-41.659% $26.77 · MISS

Nov. 6, 2024
Price Then
$66.27
Price Target
$91.03
Price Now
$64.26